PayerTalkCE Presents: Interpreting A Complex Puzzle: US Commercial Payer Coverage of Atopic Dermatitis (AD) Treatments Varies Widely

On this episode Dr. Steve Kheloussi (Highmark) engages in a fascinating discussion with Dr. James Chambers (Tufts Medical Center). They explore the intricate world of commercial health plans' coverage decisions for atopic dermatitis treatments in the US. Dr. Chambers provides insights from his extensive research into how various payers are navigating the rapidly evolving treatment landscape for AD, particularly with the advent of specialty therapies like biologics. This conversation sheds light on the significant variability in coverage policies, the evolution of these policies over time, and the impact on patient access to critical treatments. Health plan professionals will gain a deeper understanding of the challenges and considerations in formulating coverage policies for AD treatments, emphasizing the need for evidence-based decision-making and the potential implications for patient care and outcomes.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermtreatments/.

Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen